We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mary Elizabeth Hartnett

Mary Elizabeth Hartnett MD, FACS, FARVO

Distinguished Professor in Ophthalmology and Visual Sciences; Calvin S. and JeNeal N. Hatch Presidential Endowed Chair in Ophthalmology and Visual Sciences; Director of Pediatric Retina, Vitreoretinal Medical and Surgical Service; Adjunct Professor of Pediatrics and Adjunct Professor of Neurobiology and Anatomy; Principal Investigator, Retinal Angiogenesis Laboratory, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah

Mary Elizabeth Hartnett, MD, holds the Calvin S. and JeNeal N. Hatch Presidential Endowed Chair in Ophthalmology and Visual Sciences and is a Distinguished Professor at the University of Utah. She is an adjunct professor at the University of Utah departments of Neurobiology, Anatomy, and Pediatrics. Dr. Hartnett is the founder and director of Pediatric Retina at the John A. Moran Eye Center and principal investigator of the Retinal Angiogenesis Laboratory. Dr. Hartnett also serves on the Scientific Advisory Board of the Knights Templar Eye Foundation and the Jack McGovern Coats’ Disease Foundation.

As director of Moran's Pediatric Retina Center, Dr. Hartnett is one of a few pediatric retina specialists internationally trained to diagnose and treat pediatric retina disorders. She also practices as a vitreoretinal surgeon, providing treatment to patients throughout the Mountain West.

Her mission is to deliver the best possible care and education while conducting critical research to make future advances in pediatric retina care.

Some of Dr. Hartnett’s accomplishments include creating the first-ever academic textbook on Pedatric Retina and serving as director of the Advances in Pediatric Retina meeting, held every two years. Dr. Hartnett has also received numerous awards, including the Physician-Scientist Merit Award from Research to Prevent Blindness; the Honorary Lecture Award and Scientific Contribution Award from Women in Ophthalmology; the Macula Society's Paul Henkind Award and Arnall Patz Medal; the Association for Research in Vision and Ophthalmology's (ARVO) Weisenfeld Award; and the Paul Kayser/RRF Global Award. She is an ARVO Gold Fellow.

Dr. Hartnett's prolific publication record includes more than 200 articles in peer-reviewed journals and 36 book chapters. She has delivered numerous national and international invited lectures. Her long list of professional committee work includes serving as chair of the Publications Committee of ARVO, and as a mentor for the ARVO Leadership Development Program. She reviews manuscripts for more than 20 eye and science journals and serves on the editorial boards of PlosOneMolecular Vision, and the Journal of the American Association for Pediatric Ophthalmology and Strabismus.

Dr. Hartnett is a Fellow of the American College of Surgeons (FACS) and a Silver and Gold Fellow of Association for Research in Vision and Ophthalmology (FARVO).

She received her BS-MD from Rensselaer Polytechnic Institute and Albany Medical College, as part of a six-year biomedical program, and performed retinal fellowships in adult and pediatric retina at Schepens Retina Associates. Dr. Hartnett completed post-doctoral training at Harvard University/Schepens Eye Research Institute in retinal cell and molecular biology in the laboratory of Patricia D'Amore and then in GTPases and molecular cell biology at the University of North Carolina with Keith Burridge. She has served as Retinal Director for the residencies at State University of New York at Buffalo and Louisiana State University.

Disclosures

Dr. Hartnett is an an unpaid consultant for Regeneron and the aflibercept study for ROP. She has NIH grants that support her lab and salary as PI: R01EY017011 and R01EY015130.